John David Chetwood

23PUBLICATIONS
49CO-AUTHORS
Formal methods for softwareEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia.

Uma Mahadevan, Vipul Jairath, Jakob Begun

|Jul 17, 2025
Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.

Richard Parker, Guru Aithal, Michael Allison

|Jul 11, 2025
Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease.

John David Chetwood, Arteen Arzivian, Yvonne Tran

|Jan 09, 2025
Infliximab and Adalimumab in the Treatment of Fistulizing Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC4) Study.

John David Chetwood, Sudarshan Paramsothy, Rupert W Leong

|Oct 10, 2024
Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.

Rupert W Leong, Anthony Sakiris, Arteen Arzivian

|Aug 21, 2024
Genital rash: A manifestation of metastatic Crohn's disease.

John David Chetwood, Arteen Arzivian, Joo-Shik Shin

Pageof 4

Frequent Collaborators

6 joint publications

Rupert W Leong

4 joint publications

Nik Sheng Ding

4 joint publications

Ken Liu

3 joint publications

Sudarshan Paramsothy